🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
14/12/2022 0,7300 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/10/2023 99,99 103,36 99,99 102,67 +2,23% 3,37% 12.467.500
19/10/2023 101,66 101,73 99,14 100,43 -1,53% 2,55% 7.647.600
18/10/2023 104,11 104,46 101,91 101,99 -2,09% 2,45% 7.136.400
17/10/2023 104,00 104,49 103,15 104,17 +0,03% 1,29% 5.827.200
16/10/2023 104,20 105,37 104,06 104,14 +0,12% 1,26% 6.473.500
13/10/2023 103,61 104,52 102,78 104,01 +0,41% 1,68% 5.787.500
12/10/2023 103,52 103,95 102,93 103,59 +0,13% 0,99% 5.124.000
11/10/2023 104,00 104,21 102,85 103,46 -0,14% 1,31% 5.375.100
10/10/2023 104,32 104,46 103,16 103,61 -0,85% 1,25% 7.177.200
09/10/2023 103,50 105,19 103,31 104,50 +0,60% 1,82% 5.061.100
06/10/2023 103,73 104,43 102,92 103,88 +0,27% 1,46% 6.854.900
05/10/2023 102,36 103,71 102,34 103,60 +1,40% 1,34% 6.449.100
04/10/2023 101,58 102,43 101,33 102,17 +0,39% 1,08% 6.720.500
03/10/2023 102,24 102,44 100,92 101,77 -0,76% 1,49% 5.924.000
02/10/2023 102,83 102,83 101,35 102,55 -0,39% 1,44% 7.079.700
29/09/2023 104,36 104,68 102,71 102,95 -1,29% 1,89% 7.232.700
28/09/2023 104,57 104,97 103,78 104,30 +0,35% 1,14% 4.758.800
27/09/2023 105,45 105,52 103,30 103,94 -1,38% 2,11% 5.635.500
26/09/2023 105,12 106,55 105,11 105,39 -0,43% 1,37% 5.400.500
25/09/2023 106,05 106,19 105,11 105,84 -0,47% 1,02% 6.052.200
22/09/2023 107,22 107,22 105,96 106,34 -0,37% 1,18% 5.027.200
21/09/2023 107,27 107,88 106,42 106,73 -0,54% 1,36% 5.856.600
20/09/2023 108,21 108,40 107,25 107,31 -0,05% 1,06% 4.593.600
19/09/2023 107,65 108,18 106,91 107,36 -0,43% 1,18% 5.818.300
18/09/2023 107,77 107,94 106,85 107,82 +0,28% 1,01% 3.911.300
15/09/2023 108,12 108,93 107,26 107,52 -0,67% 1,54% 9.639.000
14/09/2023 107,69 108,51 106,96 108,24 +0,40% 1,44% 6.872.400
13/09/2023 108,98 109,67 107,67 107,81 -1,11% 1,84% 6.761.500
12/09/2023 108,42 109,48 107,55 109,02 +0,39% 1,78% 4.605.400
11/09/2023 109,33 109,44 108,34 108,60 -0,41% 1,01% 5.069.300